Complete Filing Data
Caribou Biosciences, Inc. reported Stockholders Equity of $122.18 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Caribou Biosciences, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$148.1M | -$149.1M | -$102.1M | -$99.4M | -$66.9M | -$34.3M | -$23.4M |
| Revenue From Contract With Customer Excluding Assessed Tax | $11.2M | $10.0M | $34.5M | $13.9M | $9.6M | $12.4M | $5.8M |
| Research And Development Expense | $109.4M | $130.2M | $112.1M | $82.2M | $52.3M | $34.4M | $23.6M |
| Operating Income Loss | -$148.3M | -$166.6M | -$116.1M | -$106.4M | -$67.0M | -$36.1M | -$34.3M |
| Operating Expenses | $159.5M | $176.6M | $150.5M | $120.3M | $76.6M | $48.5M | $40.1M |
| Nonoperating Income Expense | -$331.0K | $17.5M | $14.2M | $7.0M | $377.0K | -$3.0K | $3.3M |
| General And Administrative Expense | $37.9M | $46.5M | $38.5M | $38.0M | $24.3M | $14.1M | $16.5M |
| Other Nonoperating Income | $8.8M | $17.5M | $15.5M | $4.8M | $219.0K | $514.0K | |
| Comprehensive Income Net Of Tax | -$148.3M | -$148.9M | -$100.5M | -$100.8M | -$67.1M | -$34.3M | -$23.4M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$152.0K | $225.0K | $1.5M | -$1.4M | |||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$152.0K | $225.0K | $1.5M | -$1.4M | -$135.0K | ||
| Deferred Income Tax Liabilities Net | $0.00 | $548.0K | $557.0K | $381.0K | $476.0K | $155.0K | |
| Non Cash Consideration For Licensing And Collaboration Revenue | $9.0K | $1.6M | $61.0K | $205.0K | $0.00 | $7.6M | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$148.7M | -$149.1M | -$101.9M | -$99.4M | -$66.6M | -$36.1M | -$31.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$27.5M | -$54.1M | -$40.0M | -$34.7M | -$37.7M | -$41.2M | -$10.0M | -$29.5M | -$28.0M | -$26.6M | -$26.7M | -$19.1M | -$18.5M | -$21.0M | -$14.3M | -$13.2M | -$14.7M | -$7.9M | -$1.9M | -$9.8M |
| Revenue From Contract With Customer Excluding Assessed Tax | $2.2M | $2.7M | $2.4M | $2.0M | $3.5M | $2.4M | $23.7M | $3.8M | $3.5M | $3.3M | $4.2M | $2.7M | $2.6M | $4.0M | $1.5M | $1.6M | $984.0K | $1.2M | $8.5M | $1.7M |
| Research And Development Expense | $22.4M | $27.7M | $35.5M | $30.4M | $35.5M | $33.8M | $28.6M | $26.5M | $25.7M | $20.0M | $22.6M | $13.9M | $15.1M | $15.8M | $12.3M | $10.2M | $12.0M | $6.2M | $7.6M | $8.6M |
| Operating Income Loss | -$29.4M | -$47.6M | -$42.9M | -$38.2M | -$43.5M | -$46.0M | -$14.6M | -$32.9M | -$31.1M | -$26.5M | -$28.4M | -$20.9M | -$20.4M | -$18.6M | -$16.0M | -$13.2M | -$15.2M | -$8.2M | -$2.3M | -$10.4M |
| Operating Expenses | $31.6M | $50.2M | $45.3M | $40.3M | $47.0M | $48.4M | $38.3M | $36.6M | $34.6M | $29.8M | $32.6M | $23.5M | $23.0M | $22.6M | $17.4M | $14.8M | $16.2M | $9.4M | $10.7M | $12.1M |
| Nonoperating Income Expense | $1.9M | -$6.5M | $2.9M | $3.6M | $5.8M | $4.8M | $4.6M | $3.3M | $3.1M | -$110.0K | $1.7M | $1.8M | $2.2M | -$2.4M | $1.7M | $16.0K | $154.0K | $83.0K | $333.0K | -$573.0K |
| General And Administrative Expense | $9.2M | $10.4M | $9.7M | $9.8M | $11.5M | $14.6M | $9.7M | $10.1M | $8.9M | $9.8M | $10.0M | $9.6M | $7.9M | $6.8M | $5.1M | $4.6M | $4.2M | $3.2M | $3.2M | $3.5M |
| Other Nonoperating Income | $1.9M | $2.2M | $2.6M | $3.7M | $4.0M | $4.5M | $4.8M | $3.0M | $2.8M | $1.5M | $698.0K | $257.0K | $45.0K | $69.0K | $16.0K | $85.0K | $327.0K | |||
| Comprehensive Income Net Of Tax | -$27.5M | -$54.2M | -$40.1M | -$33.6M | -$37.7M | -$41.6M | -$9.8M | -$29.9M | -$27.3M | -$27.1M | -$27.2M | -$20.0M | -$14.3M | -$13.2M | ||||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $53.0K | -$127.0K | -$88.0K | $1.1M | $3.0K | -$352.0K | $155.0K | -$406.0K | $788.0K | -$454.0K | -$492.0K | -$954.0K | ||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $53.0K | -$127.0K | -$88.0K | $1.1M | $3.0K | -$352.0K | $155.0K | -$406.0K | $788.0K | -$454.0K | -$492.0K | -$954.0K | $0.00 | |||||||
| Deferred Income Tax Liabilities Net | $548.0K | $548.0K | $548.0K | $557.0K | $557.0K | $556.0K | $381.0K | $380.0K | $382.0K | $475.0K | $475.0K | $476.0K | $155.0K | $155.0K | ||||||
| Non Cash Consideration For Licensing And Collaboration Revenue | $0.00 | $128.0K | $0.00 | |||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$18.2M | -$21.0M | -$14.3M | -$13.2M | -$15.1M | -$8.1M | -$1.9M | -$11.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $122.2M | $253.0M | $368.4M | $300.9M | $387.8M | -$23.4M | $7.5M | $29.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $12.4M | $16.3M | $51.2M | $58.4M | $240.5M | $16.0M | $41.1M | |
| Cash And Cash Equivalents At Carrying Value | $12.4M | $16.3M | $51.2M | $58.3M | $240.4M | $16.0M | $41.1M | |
| Change In Fair Value Of Success Payments Liability | -$785.0K | -$2.2M | $1.3M | -$2.4M | $1.4M | |||
| Equity Securities Fv Ni Gain Loss | -$99.0K | -$111.0K | -$6.0K | -$133.0K | $0.00 | -$733.0K | $2.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.9M | -$34.9M | -$7.2M | -$182.1M | $224.5M | -$25.1M | -$4.6M | |
| Success Payment Liability | $0.00 | $785.0K | $2.9M | $1.7M | $4.1M | $2.7M | ||
| Retained Earnings Accumulated Deficit | -$596.5M | -$448.4M | -$299.3M | -$197.2M | -$97.8M | -$30.9M | ||
| Property Plant And Equipment Net | $6.8M | $19.3M | $18.3M | $10.7M | $4.9M | $3.5M | ||
| Prepaid Expense And Other Assets Current | $2.9M | $6.6M | $6.2M | $7.9M | $7.2M | $3.2M | ||
| Other Receivables | $1.9M | $1.8M | $2.3M | $2.2M | $5.5M | $3.7M | ||
| Other Assets Noncurrent | $2.2M | $5.5M | $1.6M | $1.5M | $975.0K | $612.0K | ||
| Liabilities Current | $25.4M | $30.7M | $28.3M | $28.1M | $25.8M | $12.4M | ||
| Liabilities And Stockholders Equity | $175.4M | $313.3M | $432.2M | $373.8M | $442.4M | $36.0M | ||
| Liabilities | $53.2M | $60.4M | $63.8M | $72.9M | $54.5M | $18.2M | ||
| Equity Method Investments | $0.00 | $9.3M | $7.8M | $7.7M | $7.6M | $7.6M | ||
| Common Stock Value | $9.0K | $9.0K | $8.0K | $6.0K | $6.0K | $1.0K | ||
| Assets Current | $145.2M | $219.4M | $338.8M | $260.2M | $391.2M | $24.3M | ||
| Assets | $175.4M | $313.3M | $432.2M | $373.8M | $442.4M | $36.0M | ||
| Accrued Liabilities Current | $16.5M | $23.6M | $21.1M | $16.1M | $13.1M | $9.0M | ||
| Accounts Receivable Net Current | $69.0K | $265.0K | $148.0K | $202.0K | $1.2M | $150.0K | ||
| Accounts Payable Current | $5.8M | $2.5M | $3.1M | $1.1M | $4.0M | $2.6M | ||
| Gain Loss On Disposition Of Assets1 | $25.0K | $9.0K | $34.0K | $0.00 | -$4.0K | -$70.0K | -$1.0K | |
| Restricted Cash And Cash Equivalents At Carrying Value | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | |||
| Accretion Amortization Of Discounts And Premiums Investments | $1.1M | $4.7M | $4.4M | $797.0K | -$52.0K | $0.00 | $0.00 | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $103.0K | $255.0K | $30.0K | -$1.5M | -$135.0K | $0.00 | ||
| Operating Lease Right Of Use Asset | $17.7M | $20.0M | $22.2M | $24.2M | $0.00 | |||
| Operating Lease Liability Noncurrent | $26.0M | $25.1M | $25.9M | $26.8M | $0.00 | |||
| Operating Lease Liability Current | $1.2M | $1.4M | $1.2M | $966.0K | $0.00 | |||
| Non Cash Lease Expense | $1.8M | $2.2M | $2.0M | $2.0M | $0.00 | |||
| Contract With Customer Liability Noncurrent | $1.8M | $3.3M | $6.1M | $16.0M | $22.0M | |||
| Contract With Customer Liability Current | $1.9M | $3.1M | $2.8M | $9.9M | $8.7M | |||
| Available For Sale Securities Debt Securities Noncurrent | $3.5M | $39.8M | $43.6M | $69.4M | $37.7M | |||
| Available For Sale Securities Debt Securities Current | $127.0M | $193.2M | $277.7M | $189.3M | $135.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $141.8M | $166.1M | $217.2M | $281.2M | $310.5M | $343.3M | $398.3M | $269.5M | $278.3M | $324.1M | $347.9M | $371.8M | $404.4M | -$47.7M | -$35.7M | -$11.2M | -$3.7M | -$2.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $11.2M | $25.2M | $29.5M | $32.0M | $37.9M | $49.4M | $104.1M | $66.2M | $52.8M | $82.1M | $112.2M | $147.7M | $435.4M | $129.6M | $145.9M | $24.5M | $33.1M | |
| Cash And Cash Equivalents At Carrying Value | $11.1M | $25.2M | $29.4M | $32.0M | $37.9M | $49.4M | $104.1M | $66.2M | $52.7M | $82.1M | $112.1M | $147.6M | $435.3M | $129.5M | $145.9M | $24.5M | $33.1M | |
| Change In Fair Value Of Success Payments Liability | $0.00 | -$451.0K | -$334.0K | $164.0K | -$1.8M | -$303.0K | $139.0K | -$279.0K | -$255.0K | $1.6M | -$1.1M | -$1.6M | $2.4M | $686.0K | ||||
| Equity Securities Fv Ni Gain Loss | -$11.0K | -$14.0K | -$102.0K | $0.00 | -$4.0K | $22.0K | -$15.0K | $31.0K | -$16.0K | -$88.0K | $0.00 | $0.00 | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $13.1M | -$1.8M | -$5.6M | -$92.8M | $130.0M | |||||||||||||
| Success Payment Liability | $0.00 | $0.00 | $451.0K | $1.0M | $841.0K | $2.6M | $1.3M | $1.1M | $1.4M | $3.0M | $1.4M | $2.5M | $6.2M | $3.8M | ||||
| Retained Earnings Accumulated Deficit | -$570.0M | -$542.5M | -$488.4M | -$412.9M | -$378.2M | -$340.5M | -$264.8M | -$254.8M | -$225.3M | -$170.2M | -$143.6M | -$116.9M | -$79.3M | -$58.3M | ||||
| Property Plant And Equipment Net | $7.6M | $8.2M | $18.5M | $19.6M | $19.9M | $19.2M | $16.6M | $15.4M | $12.6M | $9.0M | $8.0M | $6.0M | $4.5M | $4.4M | ||||
| Prepaid Expense And Other Assets Current | $5.3M | $5.8M | $6.1M | $6.6M | $6.3M | $6.9M | $7.1M | $5.6M | $6.1M | $8.6M | $7.3M | $8.2M | $6.0M | $5.0M | ||||
| Other Receivables | $1.8M | $2.0M | $1.8M | $1.7M | $1.7M | $1.7M | $2.3M | $1.5M | $1.7M | $2.7M | $3.1M | $4.2M | $5.4M | $7.6M | ||||
| Other Assets Noncurrent | $3.8M | $3.6M | $5.0M | $4.7M | $1.6M | $1.8M | $1.6M | $1.4M | $1.5M | $1.3M | $1.3M | $1.5M | $810.0K | $3.4M | ||||
| Liabilities Current | $28.1M | $28.9M | $28.5M | $32.2M | $30.9M | $29.0M | $24.6M | $34.4M | $27.1M | $28.8M | $28.9M | $26.7M | $26.2M | $26.0M | ||||
| Liabilities And Stockholders Equity | $195.0M | $220.9M | $273.7M | $344.3M | $372.9M | $406.8M | $457.5M | $349.6M | $347.5M | $398.8M | $421.4M | $446.0M | $462.0M | $158.4M | ||||
| Liabilities | $53.1M | $54.8M | $56.4M | $63.1M | $62.5M | $63.5M | $59.3M | $80.2M | $69.2M | $74.7M | $73.5M | $74.2M | $57.6M | $55.9M | ||||
| Equity Method Investments | $143.0K | $132.0K | $9.3M | $9.3M | $9.3M | $7.8M | $7.8M | $7.8M | $7.7M | $7.8M | $7.7M | $7.7M | $7.6M | $7.6M | ||||
| Common Stock Value | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $1.0K | ||||
| Assets Current | $155.5M | $192.5M | $217.3M | $237.4M | $270.9M | $304.5M | $350.7M | $268.5M | $239.5M | $306.9M | $352.9M | $368.0M | $449.0M | $143.0M | ||||
| Assets | $195.0M | $220.9M | $273.7M | $344.3M | $372.9M | $406.8M | $457.5M | $349.6M | $347.5M | $398.8M | $421.4M | $446.0M | $462.0M | $158.4M | ||||
| Accrued Liabilities Current | $19.4M | $20.5M | $19.9M | $25.4M | $23.6M | $19.0M | $18.2M | $15.9M | $12.5M | $14.6M | $14.9M | $11.2M | $13.9M | $13.3M | ||||
| Accounts Receivable Net Current | $242.0K | $71.0K | $88.0K | $184.0K | $215.0K | $917.0K | $1.1M | $766.0K | $1.5M | $397.0K | $524.0K | $374.0K | $578.0K | $2.0K | ||||
| Accounts Payable Current | $3.8M | $3.2M | $3.9M | $2.7M | $3.2M | $5.9M | $2.4M | $4.4M | $2.7M | $1.2M | $426.0K | $1.8M | $3.5M | $4.0M | ||||
| Gain Loss On Disposition Of Assets1 | $0.00 | $34.0K | $0.00 | -$3.0K | ||||||||||||||
| Restricted Cash And Cash Equivalents At Carrying Value | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | $0.00 | |||
| Accretion Amortization Of Discounts And Premiums Investments | $452.0K | $1.5M | $1.5M | -$327.0K | $0.00 | |||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $93.0K | $40.0K | $167.0K | $789.0K | -$319.0K | -$322.0K | -$981.0K | -$1.1M | -$730.0K | -$2.0M | -$1.6M | -$1.1M | ||||||
| Operating Lease Right Of Use Asset | $16.0M | $16.5M | $19.5M | $20.5M | $21.1M | $21.7M | $22.7M | $23.2M | $23.7M | $24.6M | $25.3M | $25.7M | ||||||
| Operating Lease Liability Noncurrent | $22.8M | $23.6M | $24.3M | $25.5M | $25.5M | $25.9M | $26.3M | $26.2M | $26.4M | $27.0M | $27.1M | $27.2M | ||||||
| Operating Lease Liability Current | $2.7M | $2.3M | $1.9M | $1.2M | $1.3M | $1.3M | $1.1M | $1.1M | $1.0M | $912.0K | $877.0K | $825.0K | ||||||
| Non Cash Lease Expense | $490.0K | $524.0K | $515.0K | $500.0K | $0.00 | |||||||||||||
| Contract With Customer Liability Noncurrent | $1.8M | $1.8M | $2.6M | $3.9M | $4.6M | $5.4M | $6.7M | $18.2M | $13.9M | $15.4M | ||||||||
| Contract With Customer Liability Current | $2.2M | $2.8M | $2.8M | $2.8M | $2.8M | $2.8M | $2.8M | $13.0M | $10.9M | $12.0M | ||||||||
| Available For Sale Securities Debt Securities Noncurrent | $12.0M | $0.00 | $4.0M | $52.8M | $50.1M | $51.9M | $58.2M | $33.3M | $62.5M | $49.2M | ||||||||
| Available For Sale Securities Debt Securities Current | $136.1M | $158.7M | $179.0M | $196.2M | $223.8M | $244.6M | $234.4M | $193.0M | $175.8M | $211.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $12.7M | $16.7M | $13.8M | $11.7M | $3.4M | $1.0M | $1.2M |
| Payments To Acquire Property Plant And Equipment | $1.4M | $4.9M | $11.6M | $6.5M | $2.1M | $317.0K | $884.0K |
| Net Cash Provided By Used In Operating Activities | -$111.0M | -$138.2M | -$93.3M | -$91.0M | -$32.5M | -$33.2M | -$32.0M |
| Net Cash Provided By Used In Investing Activities | $102.2M | $86.6M | -$68.2M | -$93.2M | -$176.4M | $6.4M | $27.2M |
| Net Cash Provided By Used In Financing Activities | $4.8M | $16.7M | $154.3M | $2.1M | $433.4M | $1.7M | $172.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$3.7M | $433.0K | -$1.8M | $975.0K | $4.0M | -$362.0K | $1.3M |
| Increase Decrease In Other Receivables | $76.0K | -$458.0K | $71.0K | -$3.3M | $1.8M | $540.0K | $870.0K |
| Increase Decrease In Other Operating Assets | -$3.4M | $3.9M | $48.0K | $564.0K | $316.0K | $19.0K | $298.0K |
| Increase Decrease In Contract With Customer Asset | -$152.0K | -$267.0K | -$822.0K | $759.0K | $160.0K | $492.0K | $836.0K |
| Increase Decrease In Accrued Liabilities | -$6.3M | $2.1M | $5.7M | $2.0M | $4.3M | $2.3M | $703.0K |
| Increase Decrease In Accounts Receivable | -$196.0K | $117.0K | -$54.0K | -$951.0K | $1.0M | $146.0K | -$617.0K |
| Increase Decrease In Accounts Payable | $3.3M | -$354.0K | $1.8M | -$2.7M | $1.1M | $43.0K | $1.2M |
| Depreciation Depletion And Amortization | $3.6M | $3.9M | $3.5M | $1.6M | $984.0K | $900.0K | $751.0K |
| Payments To Acquire Marketable Securities | $149.2M | $304.4M | $394.8M | $339.1M | $173.3M | $0.00 | $0.00 |
| Increase Decrease In Operating Lease Liability | -$1.3M | -$621.0K | -$637.0K | -$403.0K | $0.00 | ||
| Payments To Acquire In Process Research And Development | $0.00 | $1.6M | $0.00 | $600.0K | $1.0M | $998.0K | $0.00 |
| Increase Decrease In Contract With Customer Liability | -$2.8M | -$2.5M | -$16.9M | -$4.8M | $29.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $3.9M | $4.0M | $3.1M | $3.0M | $343.0K |
| Payments To Acquire Property Plant And Equipment | $1.0M | $1.4M | $2.0M | $723.0K | $22.0K |
| Net Cash Provided By Used In Operating Activities | -$36.7M | -$37.2M | -$27.9M | -$21.7M | $20.3M |
| Net Cash Provided By Used In Investing Activities | $49.4M | $23.0M | $20.7M | -$72.1M | -$22.0K |
| Net Cash Provided By Used In Financing Activities | $468.0K | $12.5M | $1.6M | $990.0K | $109.7M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$471.0K | $758.0K | -$1.8M | $1.3M | $562.0K |
| Increase Decrease In Other Receivables | $17.0K | -$561.0K | -$545.0K | -$1.3M | $1.1M |
| Increase Decrease In Other Operating Assets | -$479.0K | $209.0K | -$62.0K | $487.0K | $421.0K |
| Increase Decrease In Contract With Customer Asset | -$350.0K | -$454.0K | -$607.0K | $6.0K | -$355.0K |
| Increase Decrease In Accrued Liabilities | -$3.1M | -$2.2M | -$4.1M | -$2.8M | $3.9M |
| Increase Decrease In Accounts Receivable | -$177.0K | $770.0K | $1.3M | -$779.0K | -$74.0K |
| Increase Decrease In Accounts Payable | $1.4M | $2.7M | $1.5M | -$1.9M | $37.0K |
| Depreciation Depletion And Amortization | $1.2M | $710.0K | $589.0K | $308.0K | $221.0K |
| Payments To Acquire Marketable Securities | $15.5M | $71.2M | $75.9M | $110.7M | $0.00 |
| Increase Decrease In Operating Lease Liability | -$263.0K | $51.0K | -$323.0K | -$85.0K | $0.00 |
| Payments To Acquire In Process Research And Development | $0.00 | $1.5M | $0.00 | ||
| Increase Decrease In Contract With Customer Liability | -$996.0K | -$694.0K | -$1.1M | -$572.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.59 | -$1.65 | -$1.38 | -$1.64 | -$2.11 | -$4.01 | -$2.80 |
| Weighted Average Number Of Shares Outstanding Basic | 93.4M | 90.3M | 73.8M | 60.8M | 31.7M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 93.4M | 90.3M | 73.8M | 60.8M | 31.7M | ||
| Earnings Per Share Basic | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 95.1M | 92.4M | 88.4M | 61.0M | 60.3M | 9.7M | |
| Common Stock Shares Issued | 95.1M | 92.4M | 88.4M | 61.0M | 60.3M | 9.7M | |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 28.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.30 | -$0.58 | -$0.43 | -$0.38 | -$0.42 | -$0.46 | -$0.12 | -$0.48 | -$0.46 | -$0.44 | -$0.44 | -$0.32 | -$0.31 | -$0.46 | -$1.39 | -$1.39 | -$1.68 | -$0.93 | -$0.22 | -$1.16 |
| Weighted Average Number Of Shares Outstanding Basic | 93.3M | 93.0M | 92.7M | 90.5M | 90.3M | 89.3M | 83.8M | 61.4M | 61.2M | 60.9M | 60.8M | 60.5M | 45.9M | 10.3M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 93.3M | 93.0M | 92.7M | 90.5M | 90.3M | 89.3M | 83.8M | 61.4M | 61.2M | 60.9M | 60.8M | 60.5M | 45.9M | 10.3M | ||||||
| Earnings Per Share Basic | $-0.30 | $-0.58 | $-0.43 | $-0.38 | $-0.42 | $-0.46 | $-0.12 | $-0.48 | $-0.46 | $-0.44 | $-0.44 | $-0.32 | $-0.46 | $-1.39 | ||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Common Stock Shares Outstanding | 93.5M | 93.1M | 93.0M | 90.6M | 90.4M | 90.3M | 88.4M | 66.1M | 61.3M | 61.0M | 60.8M | 60.7M | 60.0M | 11.3M | ||||||
| Common Stock Shares Issued | 93.5M | 93.1M | 93.0M | 90.6M | 90.4M | 90.3M | 88.4M | 66.1M | 61.3M | 61.0M | 60.8M | 60.7M | 60.0M | 11.3M | ||||||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 44.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $16.7M | $13.8M | $11.7M | $3.4M | $1.0M | $1.2M | |
| Stock Issued During Period Value Stock Options Exercised | $6.0K | $618.0K | $793.0K | $1.5M | $2.6M | $270.0K | $217.0K |
| Stock Issued During Period Value Employee Stock Purchase Plan | $745.0K | $914.0K | $787.0K | $638.0K | |||
| Capital Expenditures Incurred But Not Yet Paid | $60.0K | $754.0K | $692.0K | $1.2M | $265.0K | $15.0K | $886.0K |
| Additional Paid In Capital | $718.6M | $701.1M | $667.6M | $499.6M | $485.7M | $7.4M | |
| Contract With Customer Asset Net Current | $1.0M | $1.2M | $1.4M | $2.2M | $1.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.9M | $3.1M | $3.9M | $4.1M | $4.7M | $4.0M | $3.5M | $3.6M | $3.1M | $2.7M | $2.9M | $3.0M | $935.0K | $593.0K | $343.0K | $248.0K | $286.0K | $237.0K |
| Stock Issued During Period Value Stock Options Exercised | $129.0K | $489.0K | $372.0K | $236.0K | $115.0K | $654.0K | $363.0K | $629.0K | $961.0K | $566.0K | $564.0K | $139.0K | $21.0K | |||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $277.0K | $6.0K | $468.0K | $246.0K | $2.0K | $667.0K | $382.0K | $404.0K | $361.0K | |||||||||
| Capital Expenditures Incurred But Not Yet Paid | $115.0K | $851.0K | $1.7M | $981.0K | $95.0K | |||||||||||||
| Additional Paid In Capital | $711.8M | $708.6M | $705.4M | $693.3M | $689.0M | $684.1M | $664.0M | $525.4M | $504.3M | $496.4M | $493.0M | $489.8M | $483.7M | $10.6M | ||||
| Contract With Customer Asset Net Current | $860.0K | $753.0K | $808.0K | $798.0K | $972.0K | $971.0K | $1.7M | $1.5M | $1.6M | $1.9M |
Most recent annual filing with the SEC: March 5, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.